Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-07
DOI
10.1038/s41598-017-17718-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model
- (2017) E Lauretti et al. Translational Psychiatry
- Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity
- (2016) Alexander Jais et al. CELL
- Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability
- (2016) Cristina García-Cáceres et al. CELL
- The insulin-like growth factor I receptor regulates glucose transport by astrocytes
- (2016) Edwin Hernandez-Garzón et al. GLIA
- The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
- (2016) Francesco Andreozzi et al. Journal of Translational Medicine
- Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
- (2016) Simon G. Patching MOLECULAR NEUROBIOLOGY
- In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
- (2016) Michael Gejl et al. Frontiers in Aging Neuroscience
- The Brief Cognitive Status Examination (BCSE): Comparing Diagnostic Utility and Equating Scores to the Mini-Mental State Examination (MMSE)
- (2015) Robin C. Hilsabeck et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™
- (2015) Patricia Kelly et al. MICROCIRCULATION
- GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
- (2015) Ethan A Winkler et al. NATURE NEUROSCIENCE
- At the Centennial of Michaelis and Menten, Competing Michaelis-Menten Steps Explain Effect of GLP-1 on Blood-Brain Transfer and Metabolism of Glucose
- (2014) Michael Gejl et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon-like Peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation
- (2013) Xie Xiao-Yun et al. MEDICAL SCIENCE MONITOR
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Plastic changes in the astrocyte GLUT1 glucose transporter and beta-tubulin microtubule protein following voluntary exercise in mice
- (2012) Angela Allen et al. BEHAVIOURAL BRAIN RESEARCH
- Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia
- (2012) Michael Gejl et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
- (2011) Ann Mosegaard Bak et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
- (2011) Berislav V. Zlokovic NATURE REVIEWS NEUROSCIENCE
- The use of PET in Alzheimer disease
- (2010) Agneta Nordberg et al. Nature Reviews Neurology
- High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio
- (2010) J. M. Ross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain glucose transporters,O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease
- (2009) Ying Liu et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of brain insulin mRNA by glucose and glucagon-like peptide 1
- (2008) Golnaz Madadi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
- (2008) Ying Liu et al. FEBS LETTERS
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
- (2008) L. Mosconi et al. JOURNAL OF NUCLEAR MEDICINE
- Brain metabolism dictates the polarity of astrocyte control over arterioles
- (2008) Grant R. J. Gordon et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started